Trailhead Biosystems Revolutionizes Regenerative Medicine with TrailBio Hematopoietic Progenitor Cells
Trailhead Biosystems expands its iPSC-derived portfolio with the introduction of TrailBio Hematopoietic Progenitor Cells, a…
Biotechnology
Aicuris Unveils Groundbreaking Pharmacokinetic Data for AIC468, a Novel Antisense Oligonucleotide Targeting BK Virus
Aicuris presents promising pharmacokinetic data from the first-in-human clinical trial of AIC468, a novel antisense…
Bionxt Solutions Makes Headway with Pending Patent Grants in Europe and Eurasia
Bionxt Solutions announces pending patent grants in Europe and Eurasia, marking significant progress in its…
Bionxt Solutions Inc. Expands Intellectual Property Portfolio with Pending Patent Grants in Europe and Eurasia
Bionxt Solutions Inc. announces pending patent grants in Europe and Eurasia, strengthening IP protection for…
Exelixis Reports Strong Q2 2025 Earnings, Boosts Stock Price
Exelixis announces impressive Q2 2025 earnings, exceeding analyst expectations and driving stock price up
Castle Biosciences Delivers Impressive Q2 Results, Surpassing Revenue Expectations
Castle Biosciences reports strong Q2 revenue, exceeding analyst estimates and demonstrating significant growth in its…
Metis Technologies Secures RMB 400 Million in Series D Financing to Fuel Beijing’s Biopharmaceutical Innovation
Metis Technologies announces the successful closure of its Series D financing round, raising RMB 400…
Beijing’s Biopharmaceutical Sector Gets Major Boost with Metis Technologies’ Series D Financing
Metis Technologies closes RMB 400 million Series D financing to drive innovation in Beijing's biopharmaceutical…
Breakthrough in Duchenne Muscular Dystrophy Treatment: Sarepta and Hansa Collaborate on Gene Therapy
Sarepta and Hansa join forces to develop a gene therapy for Duchenne muscular dystrophy, bringing…
Lilly’s Alzheimer’s Drug Shows Promising Long-Term Benefits in Extension Trial
Eli Lilly's Alzheimer's disease treatment has demonstrated long-term benefits in an extension trial, offering new…